MRIdian ViewRay Radiation Therapy System, ViewRay Treatment Planning and Delivery System (also kn...

FDA Device Recall #Z-1309-2016 — Class II — March 7, 2016

Recall Summary

Recall Number Z-1309-2016
Classification Class II — Moderate risk
Date Initiated March 7, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Viewray Incorporated
Location Oakwood Village, OH
Product Type Devices
Quantity 5 units

Product Description

MRIdian ViewRay Radiation Therapy System, ViewRay Treatment Planning and Delivery System (also known as the MRIdian¿ System) is indicated for stereotactic radiosurgery and precision radiotherapy for lesions, tumors, and conditions anywhere in the body when radiation treatment is indicated

Reason for Recall

When editing the isocenter or the couch position of the plan while in the treatment workflow (in the Points screen) and re-optimizing, the software will not prompt the user to shift the couch to the new isocenter. As a result there is the potential to deliver dose to the initial isocenter rather than the new location.

Distribution Pattern

Worldwide Distribution - US including CA, FL, MO & WI., and International distribution to the Republic of Korea and The Netherlands.

Lot / Code Information

Model number: 10000 Catalog/Part Number: 10000 Serial Numbers: 100, 101, 102, 104 & 105

Other Recalls from Viewray Incorporated

Recall # Classification Product Date
Z-0806-2016 Class II MRIdian ViewRay Radiation Therapy System, VIEWR... Dec 24, 2015
Z-0115-2016 Class II MRIdian¿ ViewRay¿ Radiation Therapy System, Vie... Aug 27, 2015
Z-1954-2015 Class II Treatment Planning and Delivery System Software... May 7, 2015
Z-2085-2015 Class II Patient Handling System (Motion Control Softwar... Apr 1, 2015
Z-1580-2015 Class II ViewRay System, Radiation Therapy System Jan 15, 2015

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.